SLC22A4 and diabetic kidney disease: Moreover, in diabetic kidney disease, octn1 might play a role in interstitial fibrosis progression by acting on expression of moesin, a protein that works as a cross-linker between the plasma membrane and actin-based cytoskeleton, and which plays a part in interstitial fibrosis even though the molecular mechanism is yet to be clarified.